Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Shield Thera Share News (STX)
STX Share
Price
STX Share
News
STX Share
Chat
STX Share
Trades54
STX
Live RNS
STX Share
Charts
STX Level 2
Console
STX Live
Share Price
STX Broker
Ratings
STX Directors
Deals
STX Financial
Diary
STX
Fundamentals
STX Short
Positions
STX
Media
STX Company
Research
STX Company
Timeline
Share Price Information for Shield Thera (STX)
Last checked at -
Last checked at 
Intraday Shield Thera Share Chart
IN BRIEF: Shield Therapeutics changes reporting currency to US dollars
Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Says it will change reporting currency to US dollars from pound sterling from 2023 results. Says the interim results for the first half of 2023 will include condensed and consolidated US dollar financial information for the period and full-year 2022.
Current stock price: 10.92 pence, up 1.6%
12-month change: down 14%
By Greg Rosenvinge, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Latest STX News
- UK earnings, trading statements calendar - next 7 days
28 Aug 2024 - TRADING UPDATES: Shield Therapeutics lands Canada win; RUA revenue up
27 Aug 2024 - Shield Therapeutics iron deficiency treatment approved in Canada
27 Aug 2024 - EXECUTIVE CHANGES: Morgan Advanced Materials picks senior director
26 Jul 2024 - Shield Therapeutics net sales grow in Q2, CEO stands down
24 Jul 2024 - EARNINGS AND TRADING: ActiveOps makes profit; Contango gets investment
3 Jul 2024 - TRADING UPDATES: NetScientific backs Wanda; Inspirit Energy wins deal
28 May 2024 - EARNINGS AND TRADING: Software Circle & Beximco report higher revenue
30 Apr 2024
Related News
EARNINGS AND TRADING: ProService Building Services lowers outlook
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...
LONDON MARKET MIDDAY: FTSE falls as US-Iran talks stall
(Alliance News) - Stock prices in London were lower at midday on Friday, as hopes of diplomatic progress in the Middle East, and a batch of domestic d...
Shield Therapeutics reports positive Q1 earnings
(Sharecast News) - Shield Therapeutics reported first-quarter net revenue of $18m and positive EBIT on Friday, helped by a China milestone payment and...
Shield Thera News
TRADING UPDATES: Shield Therapeutics lands Canada win; RUA revenue up
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Shield Therapeutics iron deficiency treatment approved in Canada
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Tuesday that 'ACCRUFeR', or ferric maltol, had been approv...
EXECUTIVE CHANGES: Morgan Advanced Materials picks senior director
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and Thursday and not separa...
Shield Therapeutics net sales grow in Q2, CEO stands down
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics said on Wednesday that total net sales had grown in Q2, driven by "robu...
EARNINGS AND TRADING: ActiveOps makes profit; Contango gets investment
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...
TRADING UPDATES: NetScientific backs Wanda; Inspirit Energy wins deal
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
EARNINGS AND TRADING: Software Circle & Beximco report higher revenue
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...
Follow the stocks
